On March 25, 2011, MAPS Lead Clinical Research Associate Berra Yazar-Klosinski, Ph.D., visited Charleston, SC, to evaluate the progress of our ongoing Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in veterans of war. The study is led by Clinical Investigators Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N. Two out of 16 subjects have now completed their MDMA-assisted psychotherapy sessions. On April 2, the third subject had his first experimental MDMA psychotherapy session. On April 4, the fourth subject was enrolled, with his first experimental therapy session scheduled for April 16. In past studies, recruitment has been the primary challenge of conducting these studies; now that we have improved our recruitment techniques, the major challenge now is making sure that all of the subjects complete the study (some could choose to drop out). It is advantageous that both of these new subjects live in the Charleston vicinity, since it dramatically reduces travel costs. Conserving resources is an important task as we conduct this study, as we still need to raise $200,000 in order to complete the study. If you would like to help us complete this crucial study, please consider making a contribution.
